Fully incorporating value into pricing will require significant effort and investment, the Novartis CEO said. Meanwhile, CVS/Caremark's Larry Merlo said the company's acquisition of Aetna opened opportunities for innovative pricing models.
CVS Health Larry Merlo announced the first retail health "concept store" focused on chronic disease opening up in the Houston, Texas market next month at the J.P. Morgan Healthcare Conference in San Francisco.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Boston, Massachusetts-based WithMe Health launched out of stealth with $20 million in funding and Oak HC/FT Partner Chris Price at the helm.
Dubbed Sharecare RX, the recently launched digital pharmacy savings card allows customers to get discounts of generic and branded medications across 68,000 pharmacies.
"Aetna believes the Divestiture is a significant step toward completing the DOJ’s review of the CVS Health Transaction," the company wrote in its SEC filing.
In a position statement, ASCO said PBM practices can result in medication dispensing errors, harm physicians' ability to treat patients and drive up costs.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Transparency in pricing negotiations is key to ensuring costs are brought down, experts say, pointing to state-level legislation to mandate it.
The PBM will incorporate cost-per-QALY analyses from ICER, but the program also drew some criticism.
CVS pulled tobacco products from the shelves of its 7,700 stores – and forfeited an estimated $2 billion in revenue – earlier than expected. It’s also illustrating the retail pharmacy industry’s push to become part of the front lines of healthcare by changing its name from CVS Caremark to CVS Health. As more patients flood […]
Just as CVS Caremark is poised to expand its MinuteClinic system, it’s inked a deal with Epic Systems to provide ambulatory electronic health record support for the clinics. The EHR/EMR giant will replace the homegrown EHR system CVS developed, according to a report by Modern Healthcare. It reflects a growing maturity of the MinuteClinic concept […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A cohort of big players in connected health is joining three former senators in pursuit of policy that supports broad use of telehealth and remote patient monitoring. Former U.S. Senate majority leaders Tom Daschle (D-S.D.) and Trent Lott (R-Miss.), along with former Sen. John Breaux (D-La.), are heading up the Alliance for Connected Care, which […]
It's a choice most working Americans eventually will have to make, experts say: Tell your insurance company how much you weigh, and how much fat you're carrying, or pay a lot more for your medical coverage. "We're going to see this a lot more," Boston ...
Cardinal Health (NYSE:CAH) renewal of a key drug distribution contract with Walgreen Co. earlier this month brings renewed focus on just how heavily reliant Cardinal is on its top two customers. In Cardinal's fiscal 2010, Walgreen (24 percent) and CVS (22 percent) combined for a 46 percent share of revenues. That's up from a combined 43 percent in 2008. Adam Fein, a pharmaceutical industry consultant with Pembroke Consulting, stated on his blog Drug Channels: "The data show a company that's increasingly at the mercy of its two dominant customers."
As you’ve probably heard, Walgreens announced yesterday it won’t fill prescriptions from patients who have CVS Caremark as their PBM. Although the decision is due to take effect gradually as contracts renew, it’s fairly dramatic news. The context for the move is that now that PBM Caremark has merged with retail chain CVS, Walgreens feels it’s […]
Highlights of the important and the interesting from the world of healthcare: Indian biotech’s prominence grows: Five years ago, big biotechnology firm collaborations in India were restricted to fee-for-service deals, but that’s changing as more and more co-development deals are struck. Indian biotechs look poised to capitalize as Big Pharma companies not only move more […]